Clicky

Memphasys Ltd  (MEM)

Description: Memphasys Limited, formerly NuSep Holdings Limited, is a bio-separations company developing and commercializing separation techniques based on its membrane technology. The Company has two main areas of focus for separating biological substances from fluids, utilizing its separation membranes and equipment: SpermSep and Hydrogel polymer membrane technology development. Its segments include Separations and Corporate. The Separations segment develops and markets the PrIME technology in both the commercial and research markets, including the ProteomeSep and SpermSep devices. Its program, SpermSep, separates the sperm from a semen sample using electrophoresis and specialist membranes. The SpermSep technology is used in fertility treatments, including in vitro fertilization (IVF) for humans and in various artificial reproductive techniques (ART) for animals. It has developed a polymer membrane separation technology using polyacrylamide hydrogel membranes with electrophoresis.


Keywords: Natural Sciences Biotechnology Technology Development Membrane Technology In Vitro Filtration Fertility Fertility Medicine In Vitro Fertilisation Assisted Reproductive Technology In Vitro Fertilization Electrophoresis Separation Process

Home Page: www.memphasys.com

MEM Technical Analysis

MFS SERIES TRUST X
,

Phone: 800-225-2606


Officers

Name Title
Ms. Alison Mary Coutts B.E., B.E. (Chem), GDipBiotech, M.B.A., MBA MD, CEO & Director
Pablo Neyertz Director of Fin.
Nick Gorring Operations Mang.
Mr. Malcolm Coleman Chief Financial Officer of Nusep Ltd
Mr. Andrew Metcalfe B.Bus, CPA, FGIA, MAICD Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.6313
Price-to-Sales TTM: 165.5405
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks